[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350923-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350923-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","impeding-the-nhej-pathway-for-overcoming-radioresistance-in-the-context-of-precision-radiotherapy-of-cancer","Impeding the NHEJ Pathway for Overcoming Radioresistance in the Context of Precision Radiotherapy of Cancer","","Non-homologous end joining (NHEJ) is a crucial DNA double-strand break repair pathway that preserves genomic stability across the cell cycle. Unlike homologous recombination, NHEJ can rapidly rejoin breaks without a homologous template, though with higher error risk. The DNA-PK complex coordinates NHEJ by recruiting and activating key factors including Artemis, XRCC4, and DNA ligase IV. NHEJ dysregulation promotes genomic instability, oncogenesis, and therapy resistance, so DNA-PK inhibitors are explored to radiosensitize tumors and improve outcomes while aiming to limit harm to normal tissues.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/impeding-the-nhej-pathway-for-overcoming-radioresistance-in-the-context-of-precision-radiotherapy-of-cancer/350923/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/impeding-the-nhej-pathway-for-overcoming-radioresistance-in-the-context-of-precision-radiotherapy-of-cancer/350923.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",15,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the role of NHEJ in DNA double-strand break repair?","Question",{"text":63,"@type":64},"NHEJ repairs DNA double-strand breaks throughout the cell cycle by directly ligating DNA ends with minimal or no need for a homologous template, enabling a rapid response but with potential for errors.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why is the DNA-PK complex central to NHEJ?",{"text":68,"@type":64},"The DNA-PK complex is described as essential for NHEJ function and ligation, as it recruits and activates additional repair factors such as Artemis, XRCC4, and DNA ligase IV.",{"name":70,"@type":61,"acceptedAnswer":71},"How do DNA-PK inhibitors help overcome radioresistance in cancer?",{"text":72,"@type":64},"Inhibiting DNA-PK is presented as a strategy to prevent recruitment and activation of the repair machinery required for DSB repair, promoting cell death through apoptosis or mitotic catastrophe and thereby radiosensitizing tumor cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350923,1790104500,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Review  \nImpeding the NHEJ Pathway for Overcoming Radioresistance in the Context of Precision Radiotherapy of Cancer  \nDragos, Andrei Niculae 1,2, Radu Marian S, erban 2, *, Dana Niculae 1,2, * and Doina Drăgănescu 1  \nAcademic Editor: Frank Wuest  \nReceived: 14 November 2025  \nRevised: 19 December 2025  \nAccepted: 24 December 2025  \nPublished: 20 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Faculty of Pharmacy, University of Medicine and Pharmacy “Carol Davila”, 37 Dionisie Lupu Street,  \n020021 Bucharest, Romania  \n2 Horia Hulubei National Institute for Physics and Nuclear Engineering, 30 Reactorului Street,  \n077125 Magurele, Romania  \n* Correspondence: [radu.serban@nipne.ro](radu.serban@nipne.ro) (R.M.S,.); [dana.niculae@nipne.ro](dana.niculae@nipne.ro) (D.N.)  \nAbstract  \nNon-homologous end joining (NHEJ) is a critical DNA double-strand break (DSB) repair pathway that operates throughout the cell cycle to maintain the genomic stability of the cell. Unlike homologous recombination (HR), NHEJ is capable of repairing DSBs without the need for a homologous template, making it a rapid response mechanism, but potentially prone to errors. Central to NHEJ function and essential for the ligation through the recruitment and activation of additional repair factors, such as Artemis, XRCC4, and DNA ligase IV, is the DNA-dependent protein kinase (DNA-PK) complex. Dysregulation in the NHEJ pathway contributes to genomic instability, oncogenesis, and resistance to genotoxic therapies. Consequently, inhibitors of DNA-PK have emerged as promising therapeutic agents to sensitize tumor cells to radiation and DNA-damaging chemotherapeutics. Inhibiting the DNA-PK ability to recruit the protein complex needed for successful DSB repair promotes cell death through apoptosis or mitotic catastrophe. While inhibitors of DNA-PK can be used to enhance the effects of genotoxic therapies, the field still struggles to address critical problems: how to best exploit the differential DNA repair capacities among tumor subtypes, how to maximize radiosensitization of cancerous cells while sparing normal tissues, and how to translate preclinical studies into clinical benefits. Given that NHEJ constitutes the primary line of defense against radiation-induced damage, rapidly repairing the majority of double-strand breaks throughout the cell cycle, this review concentrates on targeting the DNA-PK complex, as the master regulator of this rapid-response mechanism, highlighting why its inhibition represents a strategic action to overcome intrinsic radioresistance. The implementation of DNA-PK inhibitors into medical practice can enable the stratification of oncologic patients into two categories, based on the tumors’ vulnerability to NHEJ disruptions. Thus, the therapeutic pathways of patients with NHEJ tumors could branch, combining traditional genotoxic therapies (radiation and DNA-damaging chemotherapeutics) with DNA-PK inhibitors to achieve an enhanced effect and improved survival outcomes.  \nKeywords: double-strand breaks; DNA repair mechanisms; DNA-PK inhibitors  \n1. Introduction  \nIn the intricate landscape of cellular biology, the reliability of the genome is paramount, safeguarded by a network of DNA repair mechanisms that act as sentinels against genomic instability [1] . This segment will delve into the profound workings of Non-Homologous  \nEnd Joining (NHEJ), Homologous Recombination (HR), and the DNA-dependent Protein Kinase (DNA-PK) pathway (Figure 1), exploring their roles in maintaining genomic integrity while looking at the interplay of these mechanisms with the mammalian Target of Rapamycin (mTOR) signaling pathway, focusing on their potential regulatory crosstalk.  \nFigure 1. DNA damage response overview: Depending on the type, different mechanisms are employed to recognize","cbCaiowvlGCmJFsT","https://ap.wps.com/l/cbCaiowvlGCmJFsT","pdf",1849049,29,"English","# Abstract\n# 1. Introduction\n## DNA double-strand breaks (DSBs) and their sources\n## Repair pathways: NHEJ vs HR\n## Core components of NHEJ and HR","[{\"question\":\"What is the role of NHEJ in DNA double-strand break repair?\",\"answer\":\"NHEJ repairs DNA double-strand breaks throughout the cell cycle by directly ligating DNA ends with minimal or no need for a homologous template, enabling a rapid response but with potential for errors.\"},{\"question\":\"Why is the DNA-PK complex central to NHEJ?\",\"answer\":\"The DNA-PK complex is described as essential for NHEJ function and ligation, as it recruits and activates additional repair factors such as Artemis, XRCC4, and DNA ligase IV.\"},{\"question\":\"How do DNA-PK inhibitors help overcome radioresistance in cancer?\",\"answer\":\"Inhibiting DNA-PK is presented as a strategy to prevent recruitment and activation of the repair machinery required for DSB repair, promoting cell death through apoptosis or mitotic catastrophe and thereby radiosensitizing tumor cells.\"}]","Impeding the NHEJ Pathway for Overcoming Radioresistance in the Context of Precision Radiotherapy of Cancer | PDF",1790091787,73,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/807c6a05d454df6c57cb06b99753e163.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6219b32f337e560c62c05d83ac9e303.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07dcb2e941ba5ac643ec0b9094def306.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3f0185f96d1470f6b4593cdd2e7da1a.webp",980,1385]